Stenosis News and Research RSS Feed - Stenosis News and Research

A stenosis is an abnormal narrowing in a blood vessel or other tubular organ or structure.
CVRx receives HDE approval for Barostim neo legacy device

CVRx receives HDE approval for Barostim neo legacy device

CVRx, Inc., a privately held medical device company, announced today that it has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration for its Barostim neo legacy device. [More]
CVRx gets CE Mark approval to expand labeling of Barostim neo System as MR Conditional

CVRx gets CE Mark approval to expand labeling of Barostim neo System as MR Conditional

CVRx, Inc., a privately held medical device company, announced today that CE Marking has been granted to expand labeling of the Barostim neo System as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions. [More]
St. Mary's Medical Center adds Mazor Renaissance robot-assisted system to Spine Center

St. Mary's Medical Center adds Mazor Renaissance robot-assisted system to Spine Center

Dignity Health St. Mary's Medical Center has added the Mazor Robotics Renaissance computer-generated guidance system to its multidisciplinary Spine Center. St. Mary's is the only hospital in the Bay Area to exclusively offer this state-of-the-art technology for spine surgery. [More]
New study identifies crizotinib drug as possible new coating for drug-eluting stents

New study identifies crizotinib drug as possible new coating for drug-eluting stents

A new study has identified an FDA approved cancer drug, crizotinib, as a possible new coating for drug-eluting stents. Researchers found that crizotinib in mice helped prevent the narrowing of blood vessels after stenting without affecting the blood vessel lining. [More]
Researchers develop mouse model that reproduces most typical features of Noonan syndrome

Researchers develop mouse model that reproduces most typical features of Noonan syndrome

Noonan syndrome is a rare disease that is characterised by a set of pathologies, including heart, facial and skeletal alterations, pulmonary stenosis, short stature, and a greater incidence of haematological problems (mainly juvenile myeloid leukaemia, or childhood leukaemia). [More]
Study: Even mild depressive symptoms can weaken outcome of lumbar spinal stenosis surgery

Study: Even mild depressive symptoms can weaken outcome of lumbar spinal stenosis surgery

Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery. [More]
Aortic valve replacement is safe to treat severe aortic stenosis in very eldery patients

Aortic valve replacement is safe to treat severe aortic stenosis in very eldery patients

Aortic valve replacement (AVR) can safely be used to treat severe aortic stenosis in patients age 90 years and older and is associated with a low risk of operative stroke and mortality, according to a study in the November 2014 issue of The Annals of Thoracic Surgery. [More]
Lowering 'bad' cholesterol may help prevent aortic valve disease, study finds

Lowering 'bad' cholesterol may help prevent aortic valve disease, study finds

An international research team led by the Research Institute of the McGill University Health Centre and Lund University has provided new evidence that aortic valve disease may be preventable. [More]
Research findings support causal association between LDL-C, aortic valve disease

Research findings support causal association between LDL-C, aortic valve disease

In an analysis that included approximately 35,000 participants, genetic predisposition to elevated low-density lipoprotein cholesterol (LDL-C) was associated with aortic valve calcium and narrowing of the aortic valve, findings that support a causal association between LDL-C and aortic valve disease, according to a study appearing in JAMA. [More]
U-M implants CoreValve Evolut R System in patients with severe aortic stenosis

U-M implants CoreValve Evolut R System in patients with severe aortic stenosis

The University of Michigan Frankel Cardiovascular Center is one of the first hospitals in the country to implant Medtronic's new investigational device during transcatheter aortic valve replacement (TAVR). [More]
CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure. [More]
FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure). [More]
FFR guided drug-eluting stenting reduces death compared to medical therapy in stable CAD patients

FFR guided drug-eluting stenting reduces death compared to medical therapy in stable CAD patients

Fractional flow reserve (FFR)-guided drug-eluting stenting reduces death, myocardial infarction or urgent revascularisation, as compared to medical therapy in patients with stable coronary artery disease (CAD), according to the results of the FAME 2 trial presented for the first time today at ESC Congress by principal investigator Dr Bernard De Bruyne (Belgium). [More]
Measuring coronary artery blockage in heart attack patients can help avoid surgery

Measuring coronary artery blockage in heart attack patients can help avoid surgery

A method for measuring coronary artery blockage in heart attack patients can help more than one fifth of them avoid stents or surgery, according to a British study presented at the ESC Congress 2014 today. [More]
Local anaesthetic is safe, effective for transcatheter aortic valve implantation

Local anaesthetic is safe, effective for transcatheter aortic valve implantation

Local anaesthetic is as safe and effective for transcatheter aortic valve implantation (TAVI) as general anaesthetic, according to results of the FRANCE 2 registry presented at ESC Congress today by Dr Romain Chopard from France. [More]
Doctor offers four important benefits of laser back surgery

Doctor offers four important benefits of laser back surgery

The spinal column is one of the most delicate and essential areas of the human body. Signals carried to and from the brain through the column control many key functions of our motor skills and nervous system. [More]
Royal Philips receives 510(k) clearance from FDA for TAVI treatments

Royal Philips receives 510(k) clearance from FDA for TAVI treatments

Royal Philips (NYSE: PHG AEX: PHIA) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. [More]
Study could pave way for preventing brain and cardiac ischemia induced by atherosclerosis

Study could pave way for preventing brain and cardiac ischemia induced by atherosclerosis

A recent Finnish study could pave the way for preventing brain and cardiac ischemia induced by atherosclerosis. Finnish researchers have found that the low-expression variant of fatty acid-binding protein 4 (FABP4), which is particularly common among Finns, reduces the risk of heart attack and stroke. [More]
Incisionless TAVR surgery cuts length of hospital stay by 30%

Incisionless TAVR surgery cuts length of hospital stay by 30%

New research from Penn Medicine shows that incisionless transcatheter aortic valve replacement (TAVR) surgery cuts length of hospital stay by 30 percent and has no impact on post-operative vascular complication rates when compared with conventional transfemoral TAVR, which requires an incision in the groin. [More]
Boston Scientific gains CE Mark, begins European commercial launch of 25 mm Lotus TAVI System

Boston Scientific gains CE Mark, begins European commercial launch of 25 mm Lotus TAVI System

Boston Scientific Corporation has received CE Mark and begun the European commercial launch of its new 25 mm Lotus Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes. [More]